We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > anti-diabetic drug

News List

Zydus set to market generic anti-diabetic drug biospectrumasia
March 15, 2019
Zydus receives tentative approval from the USFDA for Sitagliptin and Metformin Hydrochloride Extended-Release tablets
Zydus Cadila gets USFDA nod to market generic anti-diabetic drug expressbpd
March 15, 2019
The company has received tentative approval from USFDA to market Sitagliptin and Metformin Hydrochloride extended-release tablets in the strength of 50 mg/500 mg, 50 mg/1,000 mg and 100 mg/1,000 mg
Delhi HC sets aside govt ban on Lupin's anti-diabetic drug Gluconorm-30 firstwordpharma
February 23, 2019
The Delhi High Court on Friday set aside a government notification in which it had banned Lupin's fixed-dose combination (FDC) drug Gluconorm-30, reported Business Standard.